1. Home
  2. BW vs AMPH Comparison

BW vs AMPH Comparison

Compare BW & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

N/A

Current Price

$3.59

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.39

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BW
AMPH
Founded
1867
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2015
2005

Fundamental Metrics

Financial Performance
Metric
BW
AMPH
Price
$3.59
$28.39
Analyst Decision
Strong Buy
Hold
Analyst Count
4
7
Target Price
$16.25
★ $24.50
AVG Volume (30 Days)
★ 5.1M
433.1K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.46
N/A
EPS
N/A
★ 1.67
Revenue
★ $1,062,388,000.00
$719,887,000.00
Revenue This Year
$86.64
$3.81
Revenue Next Year
$22.38
$4.91
P/E Ratio
★ N/A
$16.84
Revenue Growth
★ N/A
N/A
52 Week Low
$3.07
$16.65
52 Week High
$22.03
$31.00

Technical Indicators

Market Signals
Indicator
BW
AMPH
Relative Strength Index (RSI) 35.91 54.84
Support Level $3.07 $24.37
Resistance Level $4.68 $29.23
Average True Range (ATR) 0.51 1.26
MACD 0.05 -0.08
Stochastic Oscillator 21.57 36.22

Price Performance

Historical Comparison
BW
AMPH

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is an energy technologies provider offering energy and emissions control solutions to a broad range of industrial, electrical utility, municipal, and other customers. It offers technologies that utilize coal, natural gas, hydrogen, waste, and biomass to produce energy, environmental solutions, and carbon capture systems. The company's product portfolio comprises steam generation systems, environmental solutions, combustion and fuel systems, and related equipment and services. Additionally, it offers specialized technologies (BrightLoop) in industrial energy production, including hydrogen and syngas. Geographically, the company generates maximum revenue from the United States, and the rest from Canada, the UK, Indonesia, the Philippines, and other markets.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: